The Inhibitory Effect of 3β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells through JNK and Akt Signaling Pathway
Figure 2
Effect of 3β-hydroxy-12-oleanen-27-oic acid (ATA) on the viability of HepG2 cells. HepG2 cells were treated with ATA at indicated concentrations (0–20 μg/mL) of for 24, 48, and 72 h, respectively, and the results were expressed by percentages of surviving cells over untreated control cells using MTT assays. The values are presented as mean ± SD for three independent experiments. Significant differences with 0 μg/mL were designated as * and ***.
